Decoding the Landscape of Cytomegalovirus Research in Liver Transplantation: An In-Depth Analysis

Laurie Hung, Haneen Al-Abdallat, Aasem Rawshdeh, Esra’a Rasmi Al-Zghoul, Amani Al-Rawashdeh, Mohammad Alzoubi, Badi Rawashdeh
{"title":"Decoding the Landscape of Cytomegalovirus Research in Liver Transplantation: An In-Depth Analysis","authors":"Laurie Hung, Haneen Al-Abdallat, Aasem Rawshdeh, Esra’a Rasmi Al-Zghoul, Amani Al-Rawashdeh, Mohammad Alzoubi, Badi Rawashdeh","doi":"10.59707/hymrcqbq3107","DOIUrl":null,"url":null,"abstract":"Introduction: Cytomegalovirus (CMV), a prevalent viral infection post-liver transplantation, significantly influences transplant outcomes. This bibliometric analysis explores the evolving landscape of CMV-related research in liver transplantation, emphasizing research output and key areas of interest. \nMethods: Utilizing the Web of Science (WOS) database, we systematically searched for CMV and liver transplantation documents on October 16, 2023. R programming language, VOSviewer, and Microsoft Excel Office 365 were used for analysis. \nResults: Analyzing 801 publications on CMV-related research in liver transplantation unveiled a variable publication pattern, peaking in 2010 and 2021. \"Transplantation\" stood out as the predominant journal. Leading contributors included the University of Pittsburgh, Mayo Clinic, and the University of Washington. The United States led in contributions, followed by Spain and the United Kingdom. The analysis highlighted substantial international collaboration, notably involving the United States, the United Kingdom, Canada, China, and Italy. Key themes revolved around recipients, prophylaxis, prevention, and antiviral therapies, with ganciclovir and valganciclovir as primary medications. Recently, there has been significant discussion regarding medications such as letermovir and maribavir. \nConclusion: This research highlights the dynamic landscape of CMV infection studies, focusing on emerging trends and new medications like 'letermovir' and' maribavir'. Given the persistent challenges in transplantation, leveraging these insights is crucial for collaborative efforts and innovative research initiatives. As the transplantation community grapples with the challenges of CMV infections, our paper aims to serve as a cornerstone among contributors, fostering collaboration among authors, centers, and countries. We hope this collaboration will significantly benefit patients and elevate healthcare standards.","PeriodicalId":335220,"journal":{"name":"High Yield Medical Reviews","volume":"21 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"High Yield Medical Reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.59707/hymrcqbq3107","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Cytomegalovirus (CMV), a prevalent viral infection post-liver transplantation, significantly influences transplant outcomes. This bibliometric analysis explores the evolving landscape of CMV-related research in liver transplantation, emphasizing research output and key areas of interest. Methods: Utilizing the Web of Science (WOS) database, we systematically searched for CMV and liver transplantation documents on October 16, 2023. R programming language, VOSviewer, and Microsoft Excel Office 365 were used for analysis. Results: Analyzing 801 publications on CMV-related research in liver transplantation unveiled a variable publication pattern, peaking in 2010 and 2021. "Transplantation" stood out as the predominant journal. Leading contributors included the University of Pittsburgh, Mayo Clinic, and the University of Washington. The United States led in contributions, followed by Spain and the United Kingdom. The analysis highlighted substantial international collaboration, notably involving the United States, the United Kingdom, Canada, China, and Italy. Key themes revolved around recipients, prophylaxis, prevention, and antiviral therapies, with ganciclovir and valganciclovir as primary medications. Recently, there has been significant discussion regarding medications such as letermovir and maribavir. Conclusion: This research highlights the dynamic landscape of CMV infection studies, focusing on emerging trends and new medications like 'letermovir' and' maribavir'. Given the persistent challenges in transplantation, leveraging these insights is crucial for collaborative efforts and innovative research initiatives. As the transplantation community grapples with the challenges of CMV infections, our paper aims to serve as a cornerstone among contributors, fostering collaboration among authors, centers, and countries. We hope this collaboration will significantly benefit patients and elevate healthcare standards.
解码肝移植中巨细胞病毒研究的格局:深入分析
导言:巨细胞病毒(CMV)是肝移植术后的一种常见病毒感染,对移植结果有重大影响。本文献计量分析探讨了肝移植中巨细胞病毒相关研究的发展状况,强调了研究成果和主要关注领域。方法:利用科学网(WOS)数据库,我们系统地搜索了 2023 年 10 月 16 日的 CMV 和肝移植文献。使用 R 编程语言、VOSviewer 和 Microsoft Excel Office 365 进行分析。结果分析了801篇关于肝移植中CMV相关研究的论文,发现论文发表模式各不相同,在2010年和2021年达到高峰。"移植》是最主要的期刊。主要贡献者包括匹兹堡大学、梅奥诊所和华盛顿大学。美国的投稿量居首位,其次是西班牙和英国。分析强调了大量的国际合作,主要涉及美国、英国、加拿大、中国和意大利。关键主题围绕接受者、预防、预防和抗病毒疗法,其中更昔洛韦和缬更昔洛韦为主要药物。最近,关于来替莫韦和马立巴韦等药物的讨论也很热烈。结论本研究强调了 CMV 感染研究的动态发展,重点关注新出现的趋势和新药物,如 "来特莫韦 "和 "马立巴韦"。鉴于移植领域持续存在的挑战,利用这些见解对于合作努力和创新研究计划至关重要。在移植界努力应对 CMV 感染的挑战之际,我们的论文旨在成为贡献者之间的基石,促进作者、中心和国家之间的合作。我们希望这种合作能极大地造福患者,提高医疗水平。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信